← Open Payments lookup

MARINA TSOY-PODOSENIN: Open Payments

NPI 1881001352 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,146 in 39 payments from 8 companies in 2025. Trend: 2023 $685 · 2024 $531 · 2025 $1,146

Food & beverage: $1,034Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.12$403
E.R. Squibb & Sons, L.L.C.6$248
Alkermes, Inc.7$166
Otsuka America Pharmaceutical, Inc.6$141
Luye Pharma (USA) Ltd.3$74
Janssen Pharmaceuticals, Inc3$69
Axsome Therapeutics, Inc.1$25
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$20

Products named: UZEDY, COBENFY, ABILIFY MAINTENA, ARISTADA, ERZOFRI EXTENDED-RELEASE, INVEGA SUSTENNA, LYBALVI, VIVITROL.

Industry payments across NY — which companies pay providers there.